Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
9.84
-0.27 (-2.67%)
At close: Aug 28, 2026, 4:00 PM EDT
9.83
-0.02 (-0.15%)
After-hours: Aug 28, 2026, 4:10 PM EDT
Turn Therapeutics Market Cap
Turn Therapeutics has a market cap or net worth of $293.11 million as of August 28, 2026.
Market Cap
293.11M
Enterprise Value
288.95M
1-Year Change
n/a
Ranking
Category
Stock Price
$9.84
ChartMarket Cap Chart
Since October 8, 2025, Turn Therapeutics's market cap has increased from $196.16M to $293.11M, an increase of 49.43%. That is a compound annual growth rate of 57.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 293.11M | 152.65% |
| Dec 31, 2025 | 116.01M | -40.86% |
| Oct 8, 2025 | 196.16M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Opus Genetics | 320.30M |
| Vicore Pharma Holding AB | 318.32M |
| Orchestra BioMed Holdings | 307.14M |
| Fate Therapeutics | 304.34M |
| Bicycle Therapeutics | 303.07M |
| Cartesian Therapeutics | 301.65M |
| Fulcrum Therapeutics | 293.74M |
| Lineage Cell Therapeutics | 293.37M |